Groups to Launch Pioneering Study Aimed at Preventing Type 2 Diabetes
From staff and wire reports
The National Institutes of Health and the American Diabetes Assn. are beginning the first clinical trial designed to prevent Type 2 diabetes, which affects an estimated 14 million Americans. The five-year study will enroll 4,000 people with impaired glucose tolerance, a diabetes precursor characterized by above-normal sugar levels in the blood.
One group will make intensive lifestyle changes, which include a better diet and more exercise, two groups will receive drugs that increase the efficiency of insulin use, and the fourth will receive a placebo. The researchers hope that preventing Type 2 diabetes will eliminate the deadly complications of the disorder.
